Cablok M 25 Tablet ER
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Cilnidipine (10mg) + Metoprolol Succinate (25mg)
Overview Cablok M 25 Tablet ER
Cablok M 25 Extended-Release tablets manage hypertension (high blood pressure). This dual-action medication effectively controls blood pressure when monotherapy proves insufficient. Lowering blood pressure helps prevent future strokes and heart attacks. Take Cablok M 25 ER with or without food, consistently at the same time daily, as directed by your physician. Do not discontinue the medication independently, even feeling well, as hypertension is often asymptomatic. Stopping treatment can worsen your condition. Maintaining a healthy diet, regular exercise, and weight management further support blood pressure control. Adhere to your doctor's instructions. Potential side effects include headache, ankle edema, bradycardia, and nausea. Dizziness may occur; avoid driving or activities requiring alertness until the medication's effects are known. Elevate your legs to minimize swelling. Regular monitoring of blood pressure, kidney function, blood glucose, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues before starting treatment. Pregnant or lactating individuals should seek medical advice before use. Disclose all medications currently taken, especially those for hypertension or heart conditions.
Primary Ingredients of Cablok M 25 Tablet ER
No text was provided to rewrite.
Uses of Cablok M 25 Tablet ER
Elevated blood pressure
Major Benefits of Cablok M 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Cablok M 25 Tablet ER. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with a meal.
Common Side effects of Cablok M 25 Tablet ER:
- Abnormal phosphorous level in blood
- Hypotension (low blood pressure)
- Skin rash
How to use Cablok M 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cablok M 25 Tablet ER whole; do not crush, chew, or break it. Administer this extended-release tablet with a meal.
How Cablok M 25 Tablet ER works:
Extended-release Cablok M 25 tablets contain a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cablok M 25 Tablet ER and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Cablok M 25 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Cablok M 25 Tablet ER use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Cablok M 25 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cablok M 25 Tablet ER use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when prescribing Cablok M 25 Extended-Release tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cablok M 25 Tablet ER :
Should you forget to take a Cablok M 25 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cablok M 25 Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | HEART |
3,018 People bought this recently